参考文献/References:
[1] Koenig W,Twardella D,Brenner H,et al.Plasma co-ncentrationsof cystatin C in patientswith coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51(2):321-327.
[2] Arpegard J,Ostergren J,de Faire U,et al.Cystatin C-a marker of peripher alatherosclerotic disease?[J].Atherosclerosis,2008,199(2):397-401.
[3] Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study[J].Circulation,2007,115(2):173-179.
[4] 贺 涛,唐艺加,李 刚,等.胱抑素C水平与冠心病的相关性研究[J].中华老年心脑血管病杂志,2012,14(3):264-267.He T,Tang YJ,Li G,et al.Correlation between cystatin C level andcoronary heart disease[J].Chin J Geriatr Heart Brain Vessel Dis,2012,14(3):264-267.
[5] 蒋云华,王金良.血浆胱抑素C浓度与非慢性肾病冠心病患者冠状动脉病变严重程度的相关性[J].现代检验医学杂志,2011,26(4):42-44.
Jiang YH,Wang JL.Correlation between plasma cystatin C concentration and the severity of coronary artery disease in patients without chronic kidnev disease[J].J Mod Lab Med,2011,26(4):42-44.
[6] 陈 晨,吴海云,陈 杰,等.胱抑素C对冠心病的诊断价值及其影响因素[J].中国循证心血管医学杂志,2013,5(2):145-147.
Chen C,Wu HY,Chen J,et al.Diagnostic capability of cystatin C tocoronary heart disease and relevant influencing factors[J].Chin J Evid BasedCardiovase Med,2013,5(2):145-147.
[7] Niccoli G,Conte M,Della Bona R,et al.Cystatin C is associated with anincreased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate[J].Atherosclerosis,2008,198(2):373-380.
[8] Kiyosue A,Hirata Y,Ando J,et al.Plasma Cystatin C concentration renects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ J,2010,74(11):2441-2447.
[9] 方小丽,王 圣,马建林,等.血浆NO水平与冠脉病变稳定性的相关性研究[J].海南医学,2012,23(18):18-19.
Fang XL,Wang S,Ma JL,et al.Correlational study of the plasma NOlevels and the stability of coronary lesions[J].Hainan Medical Journal,2012,23(18):18-19.
[10] 马建林,王 圣,李新明,等.冠心病患者内皮功能与血清SOD、丙二醛含量相关[J].心脏杂志,2006,18(3):320-322.
Ma JL,Wang S,Li XM,et al.Relationship of vascular endothelial functionand content of serum superoxide dismutase and malonyldiadehyde in patients withcoronary heart disease[J].Chin Heart J,2006,18(3):320-322.
相似文献/References:
[1]武冬娜,张文杰,唐招平,等.血清Cys C和24h尿微量清蛋白定量联合检测对妊娠期糖尿病肾病的早期诊断价值[J].现代检验医学杂志,2015,30(02):139.[doi:10.3969/j.issn.1671-7414.2015.02.044]
WU Dong-na,ZHANG Wen-jie,TANG Zhao-ping,et al.Diagnostic Value of Combined Measuring of Serum Cystatin C and
24 h Urine Microalbumin in Early Gestational Diabetes Kidney Disease[J].Journal of Modern Laboratory Medicine,2015,30(01):139.[doi:10.3969/j.issn.1671-7414.2015.02.044]
[2]尹良琼,余艾霞.降钙素原、胱抑素C联合检测对脓毒症患儿28天死亡率的预测价值研究[J].现代检验医学杂志,2017,32(02):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
YIN Liang-qiong,Y Ai-xia.Predictive Value of the Combined Detection of Procalcitonin
and Cystatin C in Children with Sepsis 28 Days Mortality[J].Journal of Modern Laboratory Medicine,2017,32(01):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
[3]黄生金,郑利平,陆俊佳,等.广西地区壮族和汉族冠心病患者胱抑素C水平及其基因多态性的比较研究[J].现代检验医学杂志,2017,32(03):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
HUANG Sheng-jin,ZHENG Li-ping,LU Jun-jia,et al.Comparative Study of Cystatin C and Its Gene Polymorphism of Pati
ents
with Coronary Heart Disease between Zhuang and Han in Guangxi Region[J].Journal of Modern Laboratory Medicine,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
[4]伏彩霞a,马宝山,鲁晓波b.缺血性卒中患者血清SOD,NO,MDA水平动态变化与焦虑症发生的相关性[J].现代检验医学杂志,2018,33(06):46.[doi:10.3969/j.issn.1671-7414.2018.06.012]
FU Cai-xiaa,MA Bao-shan,LU Xiao-bob.Correlation of Dynamic Changes of Serum SOD,NO and MDA in Patients with Ischemic Stroke and Anxiety[J].Journal of Modern Laboratory Medicine,2018,33(01):46.[doi:10.3969/j.issn.1671-7414.2018.06.012]
[5]张求霞a,汪隆海a,昌国庆a,等.尿液6种蛋白与CysC水平检测对糖尿病肾病的诊断价值[J].现代检验医学杂志,2019,34(01):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
ZHANG Qiu-xiaa,WANG Long-haia,CHANG Guo-qing
a,et al.Clinical Value of Detection of 6 Proteins and Cystatin C
in Urine for Early Diagnosis of Diabetic Kidney Disease[J].Journal of Modern Laboratory Medicine,2019,34(01):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
[6]廖衍强.糖尿病并发高血压患者血清Cys C 与P 物质水平之间的关系研究[J].现代检验医学杂志,2020,35(02):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
LIAO Yan-qiang.Relationship between Serum Cys C and Substance P Levels in Patientswith Diabetes Mellitus Complicated with Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(01):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
[7]刘倩倩,鲁作华,王 星,等.血浆D- 二聚体在2 型糖尿病患者早期肾损伤中的应用价值[J].现代检验医学杂志,2020,35(04):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
LIU Qian-qian,LU Zuo-hua,WANG Xing,et al.Application Value of Serum D-Dimer in Early Kidney Injury in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(01):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
[8]安映红,李 鹏,蔡 庆,等.成年人群血清胱抑素C与同型半胱氨酸水平升高的疾病谱分析[J].现代检验医学杂志,2021,36(02):39.[doi:doi:10.3969/j.issn.1671-7414.2021.02.010]
AN Ying-hong,LI Peng,CAI Qing,et al.Disease Spectrum Analysis of Serum Hypercystatin C Accompanied by Hyperhomocysteine in Adults Polulation[J].Journal of Modern Laboratory Medicine,2021,36(01):39.[doi:doi:10.3969/j.issn.1671-7414.2021.02.010]
[9]陈丽媛.原发性高血压患者血清Ficolin-3,CysC和Hcy水平与颈动脉内膜中层厚度的相关性分析[J].现代检验医学杂志,2021,36(04):139.[doi:10.3969/j.issn.1671-7414.2021.04.030]
CHEN Li-yuan.Analysis on the Correlation between Serum Ficolin 3, Cys C and Hcy Levelsand Carotid Intima-Media Thickness in Patients with Essential Hypertension[J].Journal of Modern Laboratory Medicine,2021,36(01):139.[doi:10.3969/j.issn.1671-7414.2021.04.030]
[10]侯 越,赵 妍,王友明,等.脑卒中患者血清胱抑素C水平与卒中后认知障碍相关性的Meta分析[J].现代检验医学杂志,2022,37(02):142.[doi:10.3969/j.issn.1671-7414.2022.02.029]
HOU Yue,ZHAO Yan,WANG You-ming,et al.Meta Analysis of the Correlation between Cystatin C Level in Stroke Patientis and Post Stroke Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2022,37(01):142.[doi:10.3969/j.issn.1671-7414.2022.02.029]